Matthias Zentgraf

Title: Matthias Zentgraf: Innovator in Pharmacological Compounds

Introduction

Matthias Zentgraf is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of pharmacology, particularly through his innovative research and development of compounds that have valuable therapeutic applications.

Latest Patents

Zentgraf holds a patent for "Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use." This invention relates to compounds defined by a specific formula, which possess valuable pharmacological activity. Notably, these compounds act as inhibitors of 11β-hydroxysteroid dehydrogenase (HSD) 1, making them suitable for the treatment and prevention of diseases influenced by this enzyme, such as type 2 diabetes, obesity, and dyslipidemia. He has 1 patent to his name.

Career Highlights

Zentgraf is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work there has focused on developing innovative solutions to address various metabolic diseases. His expertise in pharmacological compounds has positioned him as a valuable asset in the research community.

Collaborations

Throughout his career, Matthias Zentgraf has collaborated with esteemed colleagues, including Frank Himmelsbach and Matthias Eckhardt. These collaborations have further enhanced his research and contributed to the advancement of pharmacological science.

Conclusion

Matthias Zentgraf's contributions to the field of pharmacology through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to have a significant impact on the treatment of metabolic diseases.